APOKYN (Tercica, Inc.)
Welcome to the PulseAid listing for the APOKYN drug offered from Tercica, Inc.. This Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Tercica, Inc. |
NON-PROPRIETARY NAME: | APOMORPHINE HYDROCHLORIDE |
SUBSTANCE NAME: | APOMORPHINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-07-02 |
END MARKETING DATE: | 0000-00-00 |
APOKYN HUMAN PRESCRIPTION DRUG Details:
Item Description | APOKYN from Tercica, Inc. |
LABELER NAME: | Tercica, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/3mL) |
START MARKETING DATE: | 2004-07-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15054-0211_750f74a5-be48-4849-be5c-ebcb6bae3dd8 |
PRODUCT NDC: | 15054-0211 |
APPLICATION NUMBER: | NDA021264 |
Other APOMORPHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: